Marjanka Kathelina Schmidt

Professor of genetic epidemiology of (breast) cancer

Utrecht University

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marjanka Kathelina Schmidt is a Professor of Genetic Epidemiology of (Breast) Cancer at Universiteit Leiden in the Netherlands. Her research focuses on various aspects of breast cancer, including genetic risk factors, prognostication methods, and the analysis of gene-environment interactions. Recent publications highlight her work on polygenic risk scores, incidence trends, and the impact of BRCA mutations on survival outcomes.

Articles (7)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Peter Bouwman

Assistant professor

NETHERLANDS

View details

Bernadette Heemskerk-Gerritsen

Erasmus MC Cancer Institute

NETHERLANDS

View details

Lisa Wiesmüller

Professor

Ulm University

GERMANY

View details

Adalgeir Arason

ICELAND

View details

Marco Montagna

Istituto Oncologico Veneto

ITALY

View details

Uffe Birk Jensen

Aarhus University

DENMARK

View details

Ralph Scully

Professor

Beth Israel Deaconess Medical Center

UNITED STATES

View details

Diana M Eccles

University of Southampton

UNITED KINGDOM

View details

Robert Winqvist

Professor

University of Oulu

FINLAND

View details

Nan Song

Assistant professor

Chungbuk National University

SOUTH KOREA

View details

Lenka Foretova

Head

Masaryk Memorial Cancer Institute

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marjanka Kathelina Schmidt

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer

Letter to the editor regarding: ‘Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis’

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017

Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study

Collaborators (11)

Peter Bouwman

Bernadette Heemskerk-Gerritsen

Lisa Wiesmüller

Adalgeir Arason

Marco Montagna

Uffe Birk Jensen

Ralph Scully

Diana M Eccles

Robert Winqvist

Nan Song

Lenka Foretova

Make your next move.